Yale Ebola clinical trial posts
Los Angeles Times Science and Health The most sought-after drug in the Ebola crisis failed to prove it helped patients. The main reason -- too few sick people to test it.
ZMapp, experimental Ebola drug, falls short in clinical trial that couldn’t find enough patients
latimes.com
ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it.
113 months ago
Yahoo A clinical trial of ZMapp is taking place in West Africa.
126 months ago
The Economist A newly published paper in the Lancet suggests an Ebola vaccine is now available. This vaccine, developed by the Public Health Agency of Canada, and called rVSV-ZEBOV, smuggles one of the Ebola virus’s coat proteins into a person’s body in a Troj Read more ... an horse called a vesicular stomatitis virus http://econ.st/1gyITlU
128 months ago
NPR One doctor who took part in the research puts it simply:
"The current data basically tells us that the vaccine works to protect people against Ebola."
New Ebola Vaccine Has '100 Percent' Effectiveness In Early Results
www.npr.org
The trial of the VSV-EBOV vaccine was called Ebola ça Suffit — French for "Ebola that's enough." Researchers say it's both effective and quick, with no new Ebola cases 6 days after vaccination.
128 months ago
TIME The National Institutes of Health may relocate its clinical trials of Ebola vaccines to Guinea, since there are no longer enough Ebola cases in Liberia for a proper efficacy trial.
Lack of Ebola Cases Shifts Vaccine Trials Away from Liberia
ti.me
Scientists are racing against the clock to create a vaccine before the outbreak is over
133 months ago
Fox News JUST IN: An American health care worker who tested positive for Ebola will be transported from Sierra Leone to the National Institutes of Health (NIH) Clinical Center in Maryland.
American Ebola Patient to Be Transported from Sierra Leone to Md.
insider.foxnews.com
This will be the second patient with Ebola virus disease admitted to the NIH Clinical Center.
133 months ago
Los Angeles Times Science and Health Clinical trial of ZMapp finally gets underway. Only some of the study participants will get the drug.
Experimental Ebola drug ZMapp begins clinical trials in Liberia
latimes.com
ZMapp, the experimental Ebola drug that won notoriety when it was given to a handful of infected aid workers at the height of the epidemic, will now begin clinical testing in Liberian treatment centers, U.S. health authorities said.
133 months ago
The New York Times Federal officials vowed to make more of an experimental drug that showed promise in treating Ebola, but those efforts have run into snags.
Fast Track on Drug for Ebola Has Faltered
nyti.ms
Government officials announced on Thursday that a clinical trial to test whether ZMapp is effective would begin in Liberia, probably within three weeks.
134 months ago
Yahoo News U.S. health officials said that they are planning to start larger, decisive clinical trials in #Liberia in the next two weeks to determine if two new #Ebola treatments under development are safe and effective.
U.S. health officials say Ebola treatment trial to start soon in Liberia
yhoo.it
(Reuters) - U.S. health officials said on Thursday that they are planning to start larger, decisive clinical trials in Liberia in the next two weeks to determine if two new Ebola treatments under development are safe and effective. One of the treatme Read more ... nts is being developed by GlaxoSmithKline and another by Newlink Genetics Corp with Merck & Co. The U.S. government and leading drugmakers have accelerated their efforts to bring a vaccine or treatmen...
134 months ago
TIMEHealthland The drug was previously used on Thomas Eric Duncan, NBC cameraman Ashoka Mukpo, and Dr. Craig Spencer
Clinical Trial for Ebola Drug Starts in Liberia
time.com
University of Oxford researchers are offering patients in Liberia a new drug for Ebola.
135 months ago